Drug intelligence / Profile preview

i-fresh DUO

Development stage: Unknown
Lead developer: DÁVI
Modality: Small Molecules
Administration: Ophthalmic

Overview

i-fresh DUO is a preservative-free, intensely moisturizing ophthalmic solution developed and marketed by the Portuguese pharmaceutical company DÁVI. Classified as a medical device, it is specifically formulated to alleviate symptoms associated with moderate to severe dry eye syndrome. The formulation typically combines sodium hyaluronate and trehalose to provide prolonged lubrication, hydration, and protection to the ocular surface. It functions by replenishing the tear film and protecting the corneal epithelium from damage caused by desiccation. The product is designed for long-lasting effect, is compatible with contact lenses, and does not cause blurred vision upon application.

Brand names: i-fresh DUO
Other names: i-fresh Duo

Beyond the preview

Go deeper on i-fresh DUO.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on i-fresh DUO.

Explore the full profile